Omclidinium inhalation powder (Anoro Ellipta)

This combined anticholinergic and beta-adrenergic agonist (LABA) drug is used to remove long-term obstruction in the airways and relieve symptoms of chronic obstructive pulmonary disease (COPD) and improve airflow in patients with chronic bronchitis and/or emphysema. Omclidinium drug is not used to treat sudden shortness of breath and improve bronchospasm attacks in asthma attacks. This medicine is taken once a day. Anoro spray is one of the so-called DPI drugs and it enters the lungs by suction or inhalation of the drug (in the form of powder) and not as a puff. The dose and amount of Omclidinium varies from person to person. This medicine should be kept in a dry and cool place away from heat and direct sunlight. Throw away the spray 6 weeks after opening or when the dose indicator reads zero (whichever comes first). Omclidinium drug is not approved for use by people under 18 years of age.

Absorption: Systemic, primarily through the lungs

Time Plasma peak: 5 to 15 minutes Metabolism: Liver

Disposal: Urine and feces

Half Life: 11 hours

Contraindications to Omclidinium medicine

• Allergy to this drug or other drugs and food such as milk protein sensitivity
• Pregnancy or intention to become pregnant and breastfeeding
• Cardiovascular problems or irregular heartbeat
• Eye disease called glaucoma
• Prostate problems or urination